China Pharma Holdings, Inc. (AMEX: CPHI) Stock Analysis & Fundamentals

CPHIChina Pharma Holdings, Inc.

AMEX · US · Healthcare · Drug Manufacturers - Specialty & Generic · chinapharmaholdings.com

1.080USD0.00%Mkt Cap: 43.76M $P/E: —2d ago

China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injecta…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.24BUSDP/E 23.7

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

$15.39BUSDP/E 118.0

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporat

Hims & Hers Health, Inc.

Lantheus Holdings Inc

$6.56BUSDP/E 24.0

AMRX

Amneal Pharmaceuticals, Inc.

$6.23BUSDP/E 37.3

INDV

Indivior PLC Ordinary Shares

$4.61BUSDP/E 14.0

HIK

Hikma Pharmaceuticals PLC

$4.32BUSDP/E 12.5

AMLX

Amylyx Pharmaceuticals Inc. Common Stock

Laboratorios Farmaceuticos Rovi, S.A.

$3.34BUSDP/E 16.6

SUPN

Supernus Pharmaceuticals, Inc.

$2.82BUSD

Key Statistics

Company

Market Cap43.76M $

Enterprise Value49.91M $

Revenue (TTM)3.91M $

Gross Profit-131.95K $

Net Income (TTM)-3.19M $

Revenue/Share0.1990 USD

Last Price1.080 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees215

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG0.16

EV/EBITDA-34.64

EV/Revenue12.75

P/S11.18

P/B1.21

EPS (TTM)-0.42

EPS (Forward)—

52W Range

0.38004% of range19.19

52W High19.19 USD

52W Low0.3800 USD

Profitability

Gross Margin-3.18%

Oper. Margin-150.98%

EBITDA Margin-36.81%

Profit Margin-76.91%

ROE-14.02%

ROA-10.28%

Growth

Revenue Growth-7.50%

Earnings Growth—

Cash Flow & Leverage

Operating CF148.26K $

CapEx (TTM)137.25K $

FCF Margin36.27%

FCF Yield3.24%

Net Debt3.45M $

Net Debt/EBITDA-2.39

Balance Sheet

Debt/Equity0.17

Current Ratio0.26

Quick Ratio0.07

Book Value/Sh0.8930 USD

Cash/Share0.0070 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:10

Split DateApr 15, 2025

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.40.52M

Float3.30M

Insiders89.63%

Institutions0.47%

Short Interest

Short Ratio0.0d

Short % Float0.42%

Short % Out.0.29%

Shares Short115.66K

Short (prev mo.)24.50K

Technical

SMA 501.086 (-0.5%)

SMA 2001.022 (+5.6%)

Beta—

S&P 52W Chg20.80%

Avg Vol (30d)9.23M

Avg Vol (10d)1.84M

Technical Indicators

RSI (14)48.3

MACD-0.0449

MACD Signal0.0029

MACD Hist.-0.0478

BB Upper1.667 USD

BB Middle1.246 USD

BB Lower0.8245 USD

BB Width67.66%

ATR (14)0.5657 USD

Vol Ratio (20d)0.03x